STAT News · Scour

STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more

statnews.com·1d

STAT+: AI medical devices’ dirty FDA secret

statnews.com·1d

Extreme heat is worsening faster for Black Americans

statnews.com·1d

STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding

statnews.com·1d

STAT+: Drug meant to make gene therapy safer may also make it less effective

statnews.com·1d

STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blame

statnews.com·1d

Opinion: RFK Jr.’s antidepressant deprescribing push gets one thing right — and others dangerously wrong

statnews.com·1d

Opinion: Access to air conditioning is critical preventive care. But federal policy treats it as optional

statnews.com·1d

Opinion: What can ‘blue zones’ really teach us about aging?

statnews.com·1d

STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career

statnews.com·1d

STAT+: Why Marty Makary was the worst FDA commissioner in 25 years

statnews.com·1d

Males who discuss suicide seek help less often than females, report finds

statnews.com·1d

STAT+: European Union inks a draft deal to boost local production of medicines and avoid shortages

statnews.com·1d

STAT+: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in

statnews.com·1d

Supreme Court extends mifepristone deadline

statnews.com·1d

STAT+: Hims takes a $33 million hit from GLP-1 ‘pivot’

statnews.com·1d

STAT+: Hims’ sales miss as telehealth competition grows

statnews.com·1d

STAT+: STAT examines America’s deadliest drug

statnews.com·2d

STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more

statnews.com·2d

STAT+: Capsida says it still doesn’t know what caused gene therapy death

statnews.com·2d

Log in to enable infinite scrolling